The innovative industry also suffered from the crisis associated with COVID – 19: many start-ups were at risk. But there are those who managed to reformat their business in time for current needs. Ekaterina Petrova, Director of GenerationS Corporate Accelerator, spoke about successful examples from its practice.
One of the practical results of the Up Great technology contest READ // ABLE may become the introduction in the near future of technologies for processing the natural language of a person (NLP, Natural Language Processing) in the practice of schools and universities, the organizers of the online conference dedicated to the contest said.
National Technological Initiative (NTI) Company InertGas Medical has developed helium-oxygen mixtures GelOx and medical equipment for their use, which may help to reduce the length of stay of patients on mechanical ventilation.
Human Stem Cells Institute Subsidiary, Center for Genetics and Reproductive Medicine Genetico have concluded a license agreement with the Mount Sinai hospital (Icahn School of Medicine at Mount Sinai) for the right to use a highly specific antigen for coronavirus SARS-CoV-2 to develop and commercialize a product for testing infected and those who have survived COVID-19.
We are in Dsight analyzed the market for corporate accelerators and hackathons for 2019. Over the past year, corporations have conducted more than 40 acceleration programs and 10 hackathons while the total cost of these activities amounted to about 800 million.
The technology business sees the crisis as not only a threat, but also an opportunity for growth. About a third of companies plan expansion — for example, projects in the field of medicine and logistics. Alexander Povalko, CEO of Russian Venture Company, told Rossiyskaya Gazeta about support measures that will compensate for some problems that have arisen and will help to support the expansion of companies.
Speaking at the Online Conference “Pandemic 2020: Opportunities and Barriers for the Innovation Sector” on April 13, Director of RVC subsidiaries Mikhail Fedotov urged all participants of the venture industry not to wait for large-scale and long-term financial assistance, but to quickly adapt their forecasts and strategies to the existing negative realities.
With the resumption of the educational process in schools, the media spread information that distance learning systems could not withstand the load due to multiple increases in the number of users. RVC conducted a situation analysis to assess the extent and possible consequences of what is happening.
Researchers at the NTI Competence Center has found a way to reduce inflammation of organs and tissues that develops with multiple sclerosis and other autoimmune diseases due to a medication that suppresses this process at the cellular level.
Organizers of the accelerator of the State Transport Leasing Company (GTLK), created on the basis of GenerationS platform of Russian Venture Company selected to support 11 technological start-ups developing new technologies in various fields of the transport industry. This was announced on Tuesday by the press service of RVC.
The creation of a fund of funds with the participation of state corporations will significantly increase the volume of venture capital in Russia, the Head of Russian Venture Company (RVC) Alexander Povalko told RIA Novosti.
The state can increase the attractiveness of corporate investments in supporting high-tech venture capital projects by introducing special conditions for calculating income taxes. This was announced to TASS on Monday by the CEO of Russian Venture Company, JSC Alexander Povalko, commenting on the possibility of creating a corporate fund of funds in the country.
The Russian company Laeneso, developing the Helsnet National Technology Initiative market, has developed an electronic stethoscope based on artificial intelligence technologies that will allow you to assess your lung conditions at home and detect signs of pneumonia, COVID-19 disease caused by a coronavirus, and other diseases in time.
Researchers at the NTI Competence Centre at the Institute of Bioorganic Chemistry (IBCh RAS) named after the RAS Academicians M.M. Shemyakin and Yu. A. Ovchinnikov RAS together with colleagues from Moscow State University named after M.V. Lomonosov created a drug designed to treat ophthalmic complications in patients with diabetes.